April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
April 12, 2024 Banks Brace for Earnings Amid Rate Cut Speculations
April 8, 2024 Robotaxi Revolution: Hype or Reality?
April 4, 2024 Yellen in China: Tackling Trade and Clean Energy Exports
Apple’s Technical Climb To $240 By Year-End
Microsoft: Decent Buying Opportunity
Apple: Why I Sold All My Shares
Why Am I Upgrading Apple Stock To ‘Buy’
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Nuvectis Pharma (NVCT) stock forecast for 2026
Updated: April 16, 2024 (06:25)
Sector: HealthcareThe share price of Nuvectis Pharma, Inc. (NVCT) now
50/200 Day Moving Average: $8.45 / $10.59
This figure corresponds to the Average Price over the previous 50/200 days. For Nuvectis Pharma stocks, the 50-day moving average is the resistance level today.
For Nuvectis Pharma stocks, the 200-day moving average is the resistance level today.
Are you interested in Nuvectis Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Nuvectis Pharma stock price in 2026. How much will one Nuvectis Pharma share be worth in 2026? Is it worth taking profit / loss on NVCT stock now or waiting? What are analysts' forecasts for Nuvectis Pharma stock?
We forecast Nuvectis Pharma stock performance using neural networks based on historical data on NVCT stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Nuvectis Pharma, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Nuvectis Pharma analysts is $22. Today 200 Day Moving Average is the resistance level (10.59 $). 50 Day Moving Average is the resistance level (8.45 $).
Historical and forecast chart of Nuvectis Pharma, Inc. stock
The chart below shows the historical price of Nuvectis Pharma stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the NVCT stock price can be found in the table below.
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
Nuvectis Pharma (NVCT) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.40 | 4.57 | 5.81 | 21.38 % |
| Feb | 4.94 | 4.17 | 5.20 | 19.92 % |
| Mar | 4.91 | 4.68 | 5.59 | 16.17 % |
| Apr | 5.42 | 4.79 | 6.00 | 20.22 % |
| May | 5.34 | 5.09 | 5.94 | 14.39 % |
| Jun | 6.07 | 5.21 | 6.41 | 18.75 % |
| Jul | 6.34 | 5.37 | 7.30 | 26.39 % |
| Aug | 5.34 | 4.66 | 5.89 | 20.83 % |
| Sep | 5.45 | 4.72 | 6.19 | 23.77 % |
| Oct | 5.86 | 5.34 | 6.50 | 17.84 % |
| Nov | 5.29 | 4.98 | 6.06 | 17.83 % |
| Dec | 5.78 | 5.50 | 6.24 | 11.85 % |
Nuvectis Pharma information and performance
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, US
Market capitalization of the Nuvectis Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of NVCT shares in the company outstanding by the market price of one share.
EBITDA of Nuvectis Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Nuvectis Pharma price target for 2026 by month
Target values for the price of one Nuvectis Pharma share for Jan 2026.
In Jan, the Negative dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 21.375% volatility is expected.
Pessimistic target level: 4.57
Optimistic target level: 5.81
Target values for the price of one Nuvectis Pharma share for Feb 2026.
In Feb, the Negative dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 19.924% volatility is expected.
Pessimistic target level: 4.17
Optimistic target level: 5.20
Target values for the price of one Nuvectis Pharma share for Mar 2026.
In Mar, the Negative dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 16.169% volatility is expected.
Pessimistic target level: 4.68
Optimistic target level: 5.59
Target values for the price of one Nuvectis Pharma share for Apr 2026.
In Apr, the Positive dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 20.217% volatility is expected.
Pessimistic target level: 4.79
Optimistic target level: 6.00
Target values for the price of one Nuvectis Pharma share for May 2026.
In May, the Negative dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 14.388% volatility is expected.
Pessimistic target level: 5.09
Optimistic target level: 5.94
Target values for the price of one Nuvectis Pharma share for Jun 2026.
In Jun, the Positive dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 18.750% volatility is expected.
Pessimistic target level: 5.21
Optimistic target level: 6.41
Target values for the price of one Nuvectis Pharma share for Jul 2026.
In Jul, the Positive dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 26.389% volatility is expected.
Pessimistic target level: 5.37
Optimistic target level: 7.30
Target values for the price of one Nuvectis Pharma share for Aug 2026.
In Aug, the Negative dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 20.833% volatility is expected.
Pessimistic target level: 4.66
Optimistic target level: 5.89
Target values for the price of one Nuvectis Pharma share for Sep 2026.
In Sep, the Positive dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 23.768% volatility is expected.
Pessimistic target level: 4.72
Optimistic target level: 6.19
Target values for the price of one Nuvectis Pharma share for Oct 2026.
In Oct, the Positive dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 17.838% volatility is expected.
Pessimistic target level: 5.34
Optimistic target level: 6.50
Target values for the price of one Nuvectis Pharma share for Nov 2026.
In Nov, the Negative dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 17.832% volatility is expected.
Pessimistic target level: 4.98
Optimistic target level: 6.06
Target values for the price of one Nuvectis Pharma share for Dec 2026.
In Dec, the Positive dynamics for Nuvectis Pharma, Inc. shares will prevail with possible monthly volatility of 11.852% volatility is expected.
Pessimistic target level: 5.50
Optimistic target level: 6.24
